# Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti‐TNF agent: a multicentre cohort study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparative-efficacy-and-safety-of-vedolizumab-and-infliximab-in-ulcerative/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marianne Hupé,Pauline Rivière,Stéphane Nancey,Xavier Roblin,Romain Altwegg,Jérôme Filippi,Mathurin Fuméry,Guillaume Bouguen,Laurent Peyrin‐Biroulet,Arnaud Bourreille,Ludovic Caillo,Mireille Simon,Félix Goutorbe,David Laharie |
| Citations | 47 |
| DOI | 10.1111/apt.15680 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3012763509 |
| PMID | 32201971 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Ludovic Caillo](https://scholariq.org/researchers/ludovic-caillo/)

## Paper journal

- [Alimentary Pharmacology & Therapeutics](https://scholariq.org/journals/alimentary-pharmacology-and-therapeutics/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.